BIG
SANA icon

Brooklyn Investment Group’s Sana Biotechnology SANA Stock Holding History

Brooklyn Investment Group’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,064
Closed -$8.37K – 2283
2025
Q2 		$8.37K Sell
3,064
-22,879
-88% -$47.2K ﹤0.01% 2258
2025
Q1 		$43.6K Buy
+25,943
New +$72.5K 0.01% 843

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brooklyn Investment Group's SANA Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Sana Biotechnology (SANA) in Q3 2025, closing a stake of 3,064 shares — an estimated $8.37K sold.

Brooklyn Investment Group first reported a position in SANA in Q1 2025 and held it in 2 quarters. The position peaked at $43.6K in Q1 2025. 178 funds tracked by Wall St. Rank hold SANA as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Sana Biotechnology position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 3,064 Sana Biotechnology shares in Q3 2025, an estimated $8.37K.
  • Brooklyn Investment Group first reported a position in Sana Biotechnology in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Sana Biotechnology position peaked at $43.6K in Q1 2025.
  • 178 funds tracked by Wall St. Rank held Sana Biotechnology as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.